ClinicalTrials.Veeva

Menu

Mandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux Disease

I

Instituto Mexicano del Seguro Social

Status

Enrolling

Conditions

Postgastrectomy Syndromes
Gastroesophageal Reflux

Study type

Observational

Funder types

Other

Identifiers

NCT06316167
Hiatoplasty-2024

Details and patient eligibility

About

The goal of this observational study is to learn about incidence of postoperative gastroesophageal reflux disease in mandatory hiatoplasty performed during gastric sleeve surgery.

The main question[s] it aims to answer are:

  • Incidence of postoperative GERD in patients undergoing gastric sleeve with mandatory hiatoplasty
  • Comparison of postoperative complication rates, including GERD

Participants will answer a follow-up questionnaire, about postoperative quality of life

Enrollment

275 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients over 18 years of age.
  • Gender indistinct.
  • Overweight, obesity grade I, II, III, super obesity or super-super obesity.
  • Underwent gastric sleeve with hiatoplasty for obesity management at a high volume Tijuana hospital dedicated to bariatric surgery.

Exclusion criteria

  • Patient records with incomplete information.

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Alejandro Gonzalez-Ojeda, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems